Register online | Log in | My Prescrire

Issue contents

• Current issue
• Last 12 issues
• All issues

Topics

• Dossiers
• Positions
• Spotlight

About Prescrire

• Who are we?
• How we work
• AMP: non-profit
• Financing
• "Non merci"
• Where to find us
• Testimonials
• Prescrire events
• A global network

Offers

• Subscribe now
• Subscribers: register online
• Prescrire’s other products

Prescrire's other websites

In Prescrire's Spotlight

The 2011 Prescrire Awards are announced in Paris This year's annual Drug Awards, announced on 26 January in Paris, included not a single winner: no "Golden Pill", no new entries to the "Honours List", not even a "Noteworthy" new drug. Prescrire's annual awards for Drug Packaging and Information were also announced. 26 January 2012

Drug research financed independently of pharmaceutical companies: for better patient care Financing of drug research by pharmaceutical companies has numerous drawbacks. Independent clinical trials should be developed, in the interest of patients. A conference-debate on this theme was held at Prescrire's annual "Pilule d'Or" ("Golden Pill")  awards ceremony, which took place in Paris on 26 January 2012. 26 January 2012

Pregnancy and alcohol: occasional, light drinking may be safe FEATURED REVIEW There is a risk of cognitive and behavioural problems in children whose mothers regularly drank more than 2 standard units of alcohol per day during pregnancy. Fetal alcohol syndrome occurs in about 5% of cases of regular exposure to five or more standard units per day. Women must be informed, but  the risks of minimal consumption should not be overstated. Full review (7 pages) available for download by subscribers. 1 February 2012

In the February issue of Prescrire International: Mobility aid-related accidents in children FREE DOWNLOAD Mobility aids for children can be a source of accidents. Wheelchairs are the devices most often involved, followed by crutches and walkers. Correct use of these devices should be explained to parents and children, and children using them should be supervised if necessary. Full text available for free download. 1 February 2012

Patients want to know Less advice, more explanations! Many patients expect healthcare professionals to help them develop their skills so they can take an active part in making decisions affecting their health. 1 February 2012

Smoking cessation: no varenicline Varenicline is used as a smoking cessation drug. It exposes patients to neuropsychological adverse effects, including depression and suicide, and there is a risk of cardiovascular events in the long term. In practice, it is better to avoid prescribing varenicline as a smoking cessation drug and to keep to nicotine when a drug treatment is deemed necessary. 1 February 2012

Outpatient care: preventable adverse events too frequent At least 40% of severe adverse events related to outpatient care that have resulted in hospitalisation appear to be preventable. They are chiefly drug-related. 1 February 2012

How a review in Prescrire is produced Prescrire’s reviews are produced through a complex, collective editing process, which has been fine-tuned over the years. The absence of any direct or indirect financial links to the pharmaceutical industry is an absolute requirement to be a member of the Prescrire team. 1 February 2012

• Sitemap |
• Terms of use |
• Contact
• |Top of page